CAPA In-vitro Oocyte Maturation for Fertility Preservation and Oocyte Retrieval in Females up to 50 Years Old

What this Trial Is About

Researchers are studying in vitro oocyte maturation IVM, a gentler assisted reproductive technology, in women facing infertility. This approach may be especially helpful for patients with polycystic ovary syndrome PCOS or those seeking fertility preservation due to treatments like chemotherapy. The study aims to explore the benefits of IVM, including its lower health risks and reduced costs compared to traditional ovarian stimulation methods. The study evaluates CAPA-IVM, a procedure where eggs mature outside the body, unlike classical IVF where ovarian stimulation affects the patient directly. This method avoids the typical risks and burdens associated with systemic ovarian stimulation. Participants will undergo the CAPA-IVM procedure, focusing on egg maturation outside the body without hormonal treatments. Participants will be monitored for the number of mature eggs obtained one week after the procedure. The study involves women and girls up to 50 years old who are seeking fertility preservation or oocyte retrieval services. Researchers will assess outcomes related to egg maturity while ensuring safety and minimizing patient burden throughout the process. The total study duration extends until May 2032.

CAPA In-vitro Oocyte Maturation